NTII: Neurobiological Technologies Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NTII: Neurobiological Technologies

NTII 0.0001000

0.0%

Dec 26 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Howard Frederick who wrote (11)	8/18/1997 9:07:00 AM
From: Dr. John M. de Castro	of 36

NTII will not have memantine trial results until probably Jan. 1998. The next news I expect is to be either the initiation of a Phase II clinical trial of Xerecept (CRF) for traumatic brain injury or a private placement to shore up NTII's financial position. It is always possible that a partnership could be announced. But, I have not seen any information or heard any rumors that suggest that one is imminent. John de C

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next